bokomslag The 2020-21 Guide to Medications for the Therapy of Diabetes Mellitus
Kropp & själ

The 2020-21 Guide to Medications for the Therapy of Diabetes Mellitus

John R White

Pocket

829:-

Funktionen begränsas av dina webbläsarinställningar (t.ex. privat läge).

Tillfälligt slut online – klicka på "Bevaka" för att få ett mejl så fort varan går att köpa igen.

  • 568 sidor
  • 2020
Newly updated to reflect the latest research and medical guidance, the 2020-21 Guide to Medications for the Treatment of Diabetes offers a bridge between drug handbooks and pharmacology texts. Focusing entirely on diabetes drugs, this reference is divided into two sections: Drugs used to manage hyperglycemia, and Management of diabetic comorbidities. The first section includes: Pharmacologic Therapy for Type 1 Diabetes Management of Hyperglycemia in Type 1 DM- info from practical use of insulin, pathophysiology, treatment strategy Insulins: RAIAs, Short-acting insulins, intermediate-acting insulins, LAIAs, Concentrated Insulins, Insulin pumps and patches, inhaled insulins, mixed and mixing insulin, use in Type 1, use in Type 2 Pharmacologic Therapy for Type 2 Diabetes Management of Hyperglycemia in Type 2- brief overview, pathophysiology, treatment strategy, overview of medications Biguanides TZDs SUs Glinides SGLT-2 Inhibitors AGIs DPP-IV inhibitors GLP Ras Amylin mimetics BARs DA-2 agonists Each chapter in Section 1 includes: Drug class overview and role in diabetes treatment Pharmacology: a. Mechanism of action, b. Pharmacokinetics Treatment Advantages/Disadvantages: General for the class, b. When applicable, a discussion of evidence that supports the benefits of using a particular drug in a class over another in the same class (eg, Avandia vs Actos) Therapeutic Considerations: a. Significant Warnings/Precautions, b. Special Populations, c. Pharmacogenomics, d. Adverse effects and monitoring, e. Drug Interactions, f. Dosage and administration Table with Doses and Dose Adjustments List of important combination products References The second section includes: Cardiovascular Disease and Risk Management Microvascular Complications and Foot Care Medications for the Management of Hypertension Medications for the Management of Hyperlipidemia Antiplatelet Therapy Medications for Smoking Cessation Medications for the Management of Neuropathy (peripheral and autonomic) Medications for the Management of Nephropathy Medications for the Management of Retinopathy Medications for the Management of Depression Medications for the Management of Hypoglycemia Medications for the Management of Obesity Immunizations in Patients with Diabetes Each chapter in Section 2 includes: An overview of the condition or problem Goals of treatment Overview of the medications and rationale for the medications used for the problem Overview of each class of medication Overview of combination therapy: a. first combination, b. second combination Doses and Dose Adjustments for the more salient medications List of important combination products References
  • Författare: John R White
  • Format: Pocket/Paperback
  • ISBN: 9781580407670
  • Språk: Engelska
  • Antal sidor: 568
  • Utgivningsdatum: 2020-10-01
  • Förlag: American Diabetes Association